The report had positive effects on the companies’ shares, although Reorg Research did not disclose the origin of the information. CVS stock spiked 3.1 percent July 12, and Aetna shares increased 2.3 percent the same day.
According to Reorg Research, Justice Department staff are expected to OK the deal. The Justice Department will make their recommendation to senior officials, who will issue a final ruling by the end of July, according to Bloomberg‘s analysis of the report.
Neither CVS nor Aetna responded to Bloomberg‘s request for comment.
More articles on transactions and valuations:
Cleveland Clinic makes foray into China
9 private equity firms vied for Envision before KKR deal: 3 things to know
Beth Israel, Lahey merger faces pushback from attorney general
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
